Lindsay Brown
Directeur/Bestuurslid bij Priority Processing Systems Pty Ltd.
Actieve functies van Lindsay Brown
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Priority Processing Systems Pty Ltd.
Priority Processing Systems Pty Ltd. Regional BanksFinance Part of Spenda Ltd., Priority Processing Systems Pty Ltd. offers financial transaction based services to consumers and retailers. Priority Processing Systems was acquired by Motopia Ltd. on March 07, 2013 for $1.03 million. | Directeur/Bestuurslid | - | - |
CU2 Global Pty Ltd.
CU2 Global Pty Ltd. Packaged SoftwareTechnology Services Part of Spenda Ltd., CU2 Global Pty Ltd. is an Australian company that helps organizations address and manage the complexity of a changing digital world. The company is based in Auburn, Australia. CU2 Global has been providing legacy application migration services to a clientele for over a decade. CU2 Global was acquired by Motopia Ltd. on November 07, 2014 for $0.09 million. | Directeur/Bestuurslid | - | - |
Loopbaan van Lindsay Brown
Eerdere bekende functies van Lindsay Brown
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Motopia Ltd.
Motopia Ltd. Packaged SoftwareTechnology Services Motopia Ltd. owns and operates technology assets. It operates through the following business segments: System Migration and App Development. The System Migration engages in the specialized or custom system migration technologies. The App Development includes development of mobile and tablet applications. The company was founded on December 18, 2001 and is headquartered in South Yarra, Australia. | Directeur/Bestuurslid | 08-03-2013 | 15-08-2014 |
Elk OrthoBiologics Ltd.
Elk OrthoBiologics Ltd. BiotechnologyHealth Technology Elk OrthoBiologics Ltd. is an Australian biotechnology company developing a minimally invasive biologic therapy for repairing aseptically loosened hip and knee prosthetic implants. It offers Gene Directed Enzyme Prodrug Therapy (GDEPT), a technology where a short acting gene therapy is used to convert a small molecule prodrug into an active drug within a target tissue. It is also a onetime treatment designed to destroy an unwanted tissue. The company is headquartered in Hawthorn East, the United Kingdom. | Voorzitter | - | - |
Statistieken
Internationaal
Australië | 5 |
Operationeel
Director/Board Member | 3 |
Chairman | 1 |
Sectoraal
Technology Services | 3 |
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Motopia Ltd.
Motopia Ltd. Packaged SoftwareTechnology Services Motopia Ltd. owns and operates technology assets. It operates through the following business segments: System Migration and App Development. The System Migration engages in the specialized or custom system migration technologies. The App Development includes development of mobile and tablet applications. The company was founded on December 18, 2001 and is headquartered in South Yarra, Australia. | Technology Services |
Priority Processing Systems Pty Ltd.
Priority Processing Systems Pty Ltd. Regional BanksFinance Part of Spenda Ltd., Priority Processing Systems Pty Ltd. offers financial transaction based services to consumers and retailers. Priority Processing Systems was acquired by Motopia Ltd. on March 07, 2013 for $1.03 million. | Finance |
CU2 Global Pty Ltd.
CU2 Global Pty Ltd. Packaged SoftwareTechnology Services Part of Spenda Ltd., CU2 Global Pty Ltd. is an Australian company that helps organizations address and manage the complexity of a changing digital world. The company is based in Auburn, Australia. CU2 Global has been providing legacy application migration services to a clientele for over a decade. CU2 Global was acquired by Motopia Ltd. on November 07, 2014 for $0.09 million. | Technology Services |
Elk OrthoBiologics Ltd.
Elk OrthoBiologics Ltd. BiotechnologyHealth Technology Elk OrthoBiologics Ltd. is an Australian biotechnology company developing a minimally invasive biologic therapy for repairing aseptically loosened hip and knee prosthetic implants. It offers Gene Directed Enzyme Prodrug Therapy (GDEPT), a technology where a short acting gene therapy is used to convert a small molecule prodrug into an active drug within a target tissue. It is also a onetime treatment designed to destroy an unwanted tissue. The company is headquartered in Hawthorn East, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Lindsay Brown
- Ervaring